These venues shutting down from London to NY & beyond to not air a 20 year old Israeli girl singing in the Eurovision really is a cultish, xenophobic, immoral, racist, dystopian flex. We’re living in a time where the cruelest, most bigoted people genuinely see themselves as light

.Avidity Biosciences, Inc. Announces #BreakthroughTherapy Designation of del-desiran by US FDA for Treatment of Adults with #MyotonicDystrophy Type 1. Read their letter to the DM1 Community at: myotonic.org/sites/default/…

Exciting News! 🎉
We're thrilled to announce the award an MSCA Doctoral Network to multiple European labs working on DM1.
We'll be recruiting talented PhD students next year.
Stay tuned for details! 🔍

#MSCA #myotonic Centre of Research in Myology (UMRS 974) Inserm Myotonic Dystrophy Foundation Institut de Myologie

An urgent appeal to my fellow parents.

Our children need us in this moment.

#consequences #nonviolence #parenting #universityprotests

From Wash U in St Louis

THIS IS THE WAY

It's not that hard, Ivy Leagues. Read and learn.

Natural history of cardiac involvement in myotonic dystrophy type 1 – Emphasis on the need for lifelong follow-up - International Journal of Cardiology internationaljournalofcardiology.com/article/S0167-…
#musculardystrophy #MDAorg #neuromuscular

Request Support for Kiggans Moskowitz Letter - Include $10 million in Myotonic Dystrophy Research Funding for CDMRP votervoice.net/Shares/BVMx8AX…

Be a #myotonicDystrophy research advocate today! Request support for Kiggans Moskowitz letter to include $10 million in #research funding for Congressionally Directed Medical Research Program (CDMRP). Advocate now: votervoice.net/Myotonic/Campa…

Orgullosa de poder participar junto a estimados colegas en este simposio en la reunión de la Sociedad Latinoamericana de Medicina de Sueño en Bogotá. Hablando sobre distrofia miotonica y trastornos del sueño entre otros temas súper interesantes. #MedicinaDelSueño #avemsu 😴🇻🇪🧬

Guillaume Bassez DM-Scope Mario Gomes-Pereira Centre of Research in Myology (UMRS 974) presenting at #IDMC14

Great work from
ARTHEx biotech to have a promising drug candidate to be evaluated VERY SOON in DM1 patients. If you want to know more contact Beatriz Llamusi
Federico Trabucchi Federación ASEM DM1 - Steinert

Exciting News for Researchers and Scholars in #MyotonicDystrophy ! During #IDMC14 MDF announces the launch of research fellowships & grants. Applications are open to for-profit and non-profit institutions around the world. Share to your network & apply: myotonic.org/request-applic…

RED-DM se visibiliza en el IDMC14, que congrega a toda la comunidad investigadora internacional en Distrofia Miotónica. Científicos, clínicos, cuidadores y pacientes se reúnen estos días para discutir los últimos avances en el estudio y tratamiento de la enfermedad. #IDMC14

Last day of this wonderful meeting! Can’t wait to see all the companies that are starting phase1-2 and phase 3 studies start recruiting for them! Exciting times for the patients and families in this community!!! #idmc14 💪🏼🤞🏼🙌🏼🙏🏼

So proud of these young investigators presenting their research. Great talent! This is the new generation of scientists that will keep the field moving forward!!! #RNAinstitute 💛💜 #GoGators 🐊

Detailed program out for International Myotonic Dystrophy Consortium Meeting starting April 9 in Nijmegen, Netherlands idmc14.org/wiki/913457/pr…

Avidity Biosciences Announces Oversubscribed $400 Million Private Placement finance.yahoo.com/news/avidity-b… via Yahoo Finance

Hoy es el Día Mundial de las Enfermedades Raras. El Grupo de Genómica Traslacional, junto a los grupos de investigación de la RED-DM nos sumamos a esta jornada de difusión para darle visibilidad a estas enfermedades que afectan a 300 millones de personas en el mundo #RedDM

.ARTHEx biotech Receives IND Clearance from the US FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for #MyotonicDystrophy Type 1. Read the full announcement at: arthexbiotech.com/post/arthex-bi…

🏥El Hospital 12 de Octubre de #Madrid participará en el #DíaMundialEnfermedadesRaras .

Con este motivo organiza el día 29 la II Jornada de Enfermedades Minoritarias con apoyo FEDER | Enfermedades Raras, AELMHU y la Sociedad Española de #MedicinaInterna Sociedad Española de Medicina Interna (SEMI).

ow.ly/oquk50QCwI7